We recently published 11 Latest Stocks Jim Cramer Talked About. The Procter & Gamble Company (NYSE:PG) is one of the stocks Jim Cramer recently discussed. The Procter & Gamble Company (NYSE:PG) is one of the largest consumer goods companies in the world. In his previous comments, Cramer has called the firm one of “the best” consumer packaged goods companies in the world. The CNBC TV host believes that The Procter & Gamble Company (NYSE:PG) is well run, which is reflected through investments in innovation ...

Key Takeaways Clorox's Q1 EPS of $0.85 beat estimates but fell 54% year over year on softer sales from its ERP shift.Net sales declined 19% to $1.43B, hurt by lower shipments and ERP-related transition impacts.The company launched its new U.S. ERP system, boosting digital strength and operational adaptability.The Clorox Company (CLX) reported first-quarter fiscal 2026 results, wherein both the top and bottom lines beat the Zacks Consensus Estimate but decreased on a year-over-year basis. Also, organic sales ...

Ibotta (NYSE:IBTA) Conference November 04, 2025 10:20 AM ET Speaker3So we're going to stay in the grocery store aisle for a little bit longer to talk about a performance marketing revolution in the consumer packaged goods segment. You probably know about this killer brand of water called Liquid Death. Have you all heard of it?Yes.Okay, yes. I am a fan of Liquid Death. Definitely all my concerts, I have a Liquid Death. So here to share some insights is the company's Chief Media Officer, Benoit, and also join ...

Changes all over the counter business for just over $40 billion. Now, you know candy was Tylenol, Neutrogena, Listerine, Band-Aids, Benadryl, and of course, Johnson's, among a host of other brands. KOMI is playing a 46% premium to create the second largest consumer packaged goods company on Earth.Second, keep that in mind. But Wall Street's skeptical about the deal. Stock plunged more than 14% today in response, falling to its lowest level since 2018.It was not a surprise, though. So what's the argument for ...

Kimberly-Clark CEO Mike Hsu told CNBC's Jim Cramer that his company's planned acquisition of Tylenol maker Kenvue will create value for shareholders, even as the the pain reliever is scrutinized by the Trump administration.He also said Tylenol sales have "seen a little bit of impact, but less than you would think" from Secretary of Health and Human Services Robert F. Kennedy Jr. and President Donald Trump promoted unfounded claims linking the use of Tylenol's active ingredient, acetaminophen, during pregnan ...

IAN MAULE / AFP / Getty Images Amazon shares climbed to an all-time high on the tech giant's $38 billion deal with OpenAI Key Takeaways Major U.S. equities indexes were mixed Monday afternoon, as tech stocks gained but most other sectors declined. Amazon shares rose to a record high on a $38 billion deal to provide AI infrastructure for OpenAI. Kenvue shares soared after Kimberly-Clark said it would buy the Tylenol maker in a nearly $49 billion deal. Major U.S. equities indexes were mixed Monday a ...

The Clorox Company (NYSE:CLX) is one of the stocks Jim Cramer had in this week’s game plan. Cramer noted the stock’s decline during the year and commented: “Now, we also hear from Clorox, quite different from Palantir, with a stock that is down more than 30% for the year. Clorox is at the heart of this market’s conundrum. In the old days, when we had worries about the economy, everybody bought the consumer packaged goods stocks. Now, perhaps because of inflation, people just won’t pay up for the name bran ...

RONALDO SCHEMIDT / AFP / Getty Images Shares of Kenvue and Kimberly-Clark have both lost about a fifth of their value in 2025 so far. Key Takeaways Kleenex and Cottonelle maker Kimberly-Clark said it's buying Tylenol maker Kenvue in a $48.7 billion deal. The transaction is expected to close in the second half of next year. Kenvue (KVUE) shares skyrocketed in early trading Monday after Kleenex and Cottonelle maker Kimberly-Clark (KMB) said it's buying the Tylenol maker in a $48.7 billion deal. Kenvu ...

This story was originally published on CIO Dive. To receive daily news and insights, subscribe to our free daily CIO Dive newsletter. Dive Brief: Colgate-Palmolive plans to pursue agentic AI adoption as part of its 2030 growth strategy, according to the company’s Q3 2025 financial report Friday.  After scaling digital, data and analytics capabilities, the company plans to accelerate investments and efforts in revenue growth management and agentic AI, said Noel Wallace, chairman, CEO and president, speak ...

Rick Dierker: In 3Q, our adjusted tax rate was 21.6%, compared to 23.3% of 2024, a 170 basis point year-over-year decrease. The expected adjusted effective tax rate for the year is now 22.5%. Now to cash. We delivered strong cash results in the quarter as cash flow from operations increased 19.6% versus last year to $435.5 million. Capital expenditures for the first nine months were $67.2 million, a $58 million decrease from the prior year due to a return to normalized capital spending in 2025. Finally, in ...